- Home
- KYMR vs LLYVA Comparison
KYMR vs LLYVA Comparison
Compare KYMR & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | LLYVA |
|---|---|---|
| Founded | 2015 | 1991 |
| Country | United States | United States |
| Employees | N/A | 54700 |
| Industry | Medicinal Chemicals and Botanical Products | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | LLYVA |
|---|---|---|
| Price | $119.06 | $103.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 26 | 0 |
| Target Price | ★ $107.72 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 287.4K |
| Earning Date | 04-30-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $10.61 | N/A |
| Revenue Next Year | $8.17 | $5.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $36.88 | $74.38 |
| 52 Week High | $130.05 | $105.48 |
Technical Indicators
Market Signals| Indicator | KYMR | LLYVA |
|---|---|---|
| Relative Strength Index (RSI) | 76.01 | 63.76 |
| Support Level | $72.91 | $86.31 |
| Resistance Level | $130.05 | N/A |
| Average True Range (ATR) | 7.67 | 3.38 |
| MACD | 2.01 | 0.69 |
| Stochastic Oscillator | 76.15 | 81.47 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About LLYVA Liberty Media Corporation Series A Liberty Live
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.